Ex vivo generation of platelet products from human iPS cells
Abstract Platelet products are used in treatments for thrombocytopenia caused by hematopoietic diseases, chemotherapy, massive hemorrhages, extracorporeal circulation, and others. Their manufacturing depends on volunteers who donate blood. However, it is becoming increasingly necessary to reinforce...
Wedi'i Gadw mewn:
Prif Awduron: | Sou Nakamura (Awdur), Naoshi Sugimoto (Awdur), Koji Eto (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
BMC,
2020-12-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming
gan: Dilip Dey, et al.
Cyhoeddwyd: (2011) -
iPS Cells for Modelling and Treatment of Human Diseases
Cyhoeddwyd: (2015) -
Quantitative analysis of intraneuronal transport in human iPS neurons
gan: Haruko Nakamura, et al.
Cyhoeddwyd: (2015) -
Ex Vivo Generated Red Cells as Transfusion Products
gan: Anna Rita Migliaccio, et al.
Cyhoeddwyd: (2012) -
The Promise and Therapeutic Potential of Human ES and iPS Cells
gan: Shi-Jiang Lu, et al.
Cyhoeddwyd: (2011)